# 2026-09011: FDA Greenlights Generics for MICARDIS Blood Pressure Pills

2026-09011, Determination That MICARDIS (Telmisartan), Tablets, 20 Milligrams and 80 Milligrams, Were Not Withdrawn From Sale for Reasons of Safety or Effectiveness, is a Federal Register notice from Health and Human Services Department, Food and Drug Administration published 2026-05-07, effective 2026-05-07; PRIA reads it as touching household money (as of 2026-06-08).

- Canonical: https://policyrisk.com/federal-register/2026-09011
- As of: 2026-06-08
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2026-09011
- Title: Determination That MICARDIS (Telmisartan), Tablets, 20 Milligrams and 80 Milligrams, Were Not Withdrawn From Sale for Reasons of Safety or Effectiveness
- Type: Notice
- Agencies: Health and Human Services Department; Food and Drug Administration
- Citation: 91 FR 24878
- Published: 2026-05-07
- Effective: 2026-05-07
- Comments close: not stated
- Significant: no
- Touches household money: yes
- Regulation identifier numbers: none
- Last updated: 2026-06-08

## In one line

FDA Greenlights Generics for MICARDIS Blood Pressure Pills

## Summary

The FDA has decided that MICARDIS tablets (20 mg and 80 mg) were not taken off the market because of safety or effectiveness problems. This means generic versions can keep getting approved, helping patients access affordable options without delays. If you use or make these meds, no sudden changes or extra costs are coming your way anytime soon!

## Abstract

The Food and Drug Administration (FDA, Agency, or we) has determined that MICARDIS (telmisartan), tablets, 20 milligrams (mg) and 80 mg, were not withdrawn from sale for reasons of safety or effectiveness. This determination means that FDA will not begin procedures to withdraw approval of abbreviated new drug applications (ANDAs) that refer to these drug products, and it will allow FDA to continue to approve ANDAs that refer to these products as long as they meet relevant legal and regulatory requirements.

## Effects PRIA read

- MICARDIS Generics Can Continue: benefit, medium. The FDA determined on May 7, 2026 that MICARDIS (telmisartan) tablets, 20 mg and 80 mg, were not withdrawn from sale for reasons of safety or effectiveness. Because of this, FDA will not begin procedures to withdraw approval of abbreviated new drug applications (ANDAs) that refer to these products…

## Related documents

- [2026-20848](https://policyrisk.com/federal-register/2026-20848): Use of Salt Substitutes To Reduce the Sodium Content in Standardized Foods, 2026-10-13
- [2026-16296](https://policyrisk.com/federal-register/2026-16296): Substances Generally Recognized as Safe, 2026-08-11
- [2026-14073](https://policyrisk.com/federal-register/2026-14073): Drug Establishment Registration and Drug Listing Requirements for Establishments Engaged in Distributed Manufacturing and Certain Foreign E…, 2026-07-13
- [2026-13047](https://policyrisk.com/federal-register/2026-13047): Establishment Registration and Product Listing for Tobacco Products, 2026-06-29
- [2025-04978](https://policyrisk.com/federal-register/2025-04978): Nonprescription Drug Product With an Additional Condition for Nonprescription Use, 2025-03-25
- [2025-01840](https://policyrisk.com/federal-register/2025-01840): Nonprescription Drug Product With an Additional Condition for Nonprescription Use, 2025-01-27

## Sources
- [2026-09011 on federalregister.gov](https://www.federalregister.gov/documents/2026/05/07/2026-09011/determination-that-micardis-telmisartan-tablets-20-milligrams-and-80-milligrams-were-not-withdrawn)
- [2026-09011 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2026-05-07/pdf/2026-09011.pdf)

## Related
- [Previous: 2026-09008, Arms Sales Notification](https://policyrisk.com/federal-register/2026-09008)
- [Next: 2026-09012, Teva Pharmaceuticals USA, Inc., et al.; Withdrawal of Approval of 15 Abbreviate…](https://policyrisk.com/federal-register/2026-09012)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2026-09011 (as of 2026-06-08).
